# Breakthrough Victoria

> Breakthrough Victoria is a VC fund backing Health Care and Manufacturing. See 55 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Melbourne, Australia
- Total investments: 55
- Last investment: May 2026
- Lead investor: 53%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/breakthrough-victoria
- Website: http://www.breakthroughvictoria.com/

Breakthrough Victoria is a VC fund in Melbourne focused on Health Care and Manufacturing. The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.

## Contacts

5 contacts available for Breakthrough Victoria. Shizune tracks 3 team members at Breakthrough Victoria. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/breakthrough-victoria?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $708k–$6.8M |
| Series A | $4M–$35M |
| Venture - Series Unknown | $500k–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 11 | 20% |
| Manufacturing | 10 | 18% |
| Biotechnology | 7 | 13% |
| Medical | 5 | 9% |
| Medical Device | 5 | 9% |

58 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 13 | 24% |
| Venture - Series Unknown | 10 | 18% |
| Series A | 8 | 15% |
| Pre-Seed | 7 | 13% |
| Series B | 3 | 5% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Australia | 35 | 64% |
| United States | 4 | 7% |
| Philippines | 2 | 4% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Lauren Morrey | Executive Director Development | 1 | https://shizune.co/investors/profile/lauren-morrey-aa5d |
| Rod Bristow | CEO | 11 | https://shizune.co/investors/profile/rod-bristow |
| Josh Funder | Director | 0 | https://shizune.co/investors/profile/josh-funder |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AlleSense | AlleSense develops a label-free optical imaging technology designed to enhance disease diagnosis by manipulating light-tissue interactions at the nanoscale. It's Mission is to Reimagining the standard microscope slide to make digital pathology faster, more accurate, and accessible without complex chemical staining. | $1.8M | Seed | May 28, 2026 |  |
| Deftbiotech | Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections. | $1M | Pre-Seed | Mar 20, 2026 |  |
| Mental Jam | We are a games studio dedicated to ​creating impactful experiences that ​explore mental health. | $97.6K | Pre-Seed | Oct 15, 2025 |  |
| DeepDerm | DeepDerm is developing AI-enabled cameras that detect skin cancer without the need for painful biopsies. | $97.6K | Seed | Oct 15, 2025 |  |
| InnovaIVF | InnovaIVF transforms the reproductive technology landscape with innovative solutions. | $97.6K | Pre-Seed | Oct 15, 2025 |  |
| Harvest B | Plant-based meat startup that develops plant-based ingredients for plant-based meat producers by leveraging a smart ingredient system | $2M | Seed | Sep 12, 2025 |  |
| Remagine Labs | Remagine Labs is revolutionizing healthcare with a bluetooth-connected, wearable electro-pharmaceutical that provide patient-centered care and consistent drug administration, giving healthcare customers peace of mind all over the world. |  | Pre-Seed | Aug 01, 2025 |  |
| Fyton Bio | FytonBio is a privately held, preclinical-stage biopharmaceutical company specializing in biotechnology research. Their core mission is to achieve functional cures for autoimmune and inflammatory diseases by deleting pathogenic immune cells. The company focuses on developing monoclonal antibodies capable of highly specific depletion of such cellsto durably alter disease progression. |  | Pre-Seed | Aug 01, 2025 |  |
| Myostellar | Myostellar is creating a first-in-class, highly differentiated biologic therapy that stimulates muscle stem cells to promote muscle regeneration with no fibrosis. |  | Pre-Seed | Aug 01, 2025 |  |
| Amber Electric | Amber Electric is an energy retailer and technology-driven electricity provider that supplies households with access to real-time wholesale electricity pricing. The company operates by passing through wholesale market prices directly to customers rather than using traditional fixed retail tariffs, allowing electricity costs to fluctuate based onsupply and demand conditions in the energy market. The business provides a digital platform that enables customers to monitor electricity prices in real time and adjust their usage patterns to periods when energy is cheaper and more abundant. It also integrates with home solar systems, batteries, and electric vehicles, allowing users to automate energy consumption, storage, and export decisions to optimize cost outcomes and energy efficiency.Amber develops software tools and automation systems that support dynamic energy management, including smart scheduling features and integration with connected home energy devices. These tools are designed to help customers shift energy-intensive activities and battery charging to periods of lower wholesale prices and higher renewable energy availability. The company also supports distributed energy resources by enabling households with solar panels and batteries to participate more actively in the electricity market. Through this model, excess stored energy can be exported back to the grid during higher price periods, aligning household energy use with grid conditions and renewable generation levels. | $29.7M | Venture - Series Unknown | Jun 04, 2025 |  |

10 of 55 investments shown.

## Co-investors
- [Investible](https://shizune.co/investors/profile/investible) — VC Fund, 9 deals together
- [Main Sequence Ventures](https://shizune.co/investors/profile/main-sequence-ventures) — VC Fund, 9 deals together
- [Gentrack Group](https://shizune.co/investors/profile/gentrack-group) — VC Fund, 5 deals together
- [Alberts Impact Ventures](https://shizune.co/investors/profile/alberts-impact-capital) — VC Fund, 4 deals together
- [InterValley Ventures](https://shizune.co/investors/profile/intervalley-ventures-pty-ltd) — VC Fund, 4 deals together
- [Boson Ventures](https://shizune.co/investors/profile/boson-ventures-64cb) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Artesian VC](https://shizune.co/investors/profile/artesian-capital-management) — VC Fund
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund

## Featured in investor lists
- [All Investors in Australia](https://shizune.co/investors/investors-australia)
- [All VC Funds in Australia](https://shizune.co/investors/vc-funds-australia)
- [All Investors in Oceania](https://shizune.co/investors/investors-oceania)
- [All VC Funds in Oceania](https://shizune.co/investors/vc-funds-oceania)
- [Health Care VC Funds in Australia](https://shizune.co/investors/health-care-vc-funds-australia)
- [Health Care Investors in Australia](https://shizune.co/investors/health-care-investors-australia)

## FAQ

### What does Breakthrough Victoria invest in?

Breakthrough Victoria invests primarily in Health Care, Manufacturing and Biotechnology startups, most often at Seed and Venture - Series Unknown stage. Most of the 55 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Breakthrough Victoria's check size?

Breakthrough Victoria typically joins rounds of $708k–$6.8M at Seed, $4M–$35M at Series A and $500k–$30M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Breakthrough Victoria participates in.

### How do I contact Breakthrough Victoria?

Public channels for Breakthrough Victoria include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Breakthrough Victoria?

The team at Breakthrough Victoria includes Lauren Morrey (Executive Director Development), Rod Bristow (CEO) and Josh Funder (Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co